Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva gains on earnings beat
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
Teva Pharmaceuticals on Twitter: "Teva just announced its Q2 2022 financial results. View the press release here: https://t.co/OGECc00hWU Forward-looking statements are subject to the cautionary note included in our Q2 2022 press
Teva Pharmaceutical Is in Recovery - WSJ
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Q3 pharma earnings roundup: Moderna, Regeneron and Teva